Adrian Rawcliffe
Overview
Adrian Rawcliffe received an average of $2M in total compensation, including $481K in salary, at Adaptimmune Therapeutics from 2015 to 2021.
2021Adaptimmune TherapeuticsChief Executive Officer
2020Adaptimmune TherapeuticsChief Executive Officer
2019Adaptimmune TherapeuticsChief Executive Officer
2018Adaptimmune TherapeuticsChief Financial Officer
2017Adaptimmune TherapeuticsChief Financial Officer
2016Adaptimmune TherapeuticsChief Financial Officer
2015Adaptimmune TherapeuticsChief Financial Officer
Source: SEC filings on April 21, 2022, April 20, 2020, March 15, 2019, April 27, 2018, and April 28, 2017.
Related executives
We found six more executives who work or worked at Adaptimmune Therapeutics.
Helen Tayton-Martin
Adaptimmune Therapeutics
Chief Business Officer
William Bertrand
Adaptimmune Therapeutics
Chief Operating Officer
Gavin Wood
Adaptimmune Therapeutics
Chief Financial Officer
John Lunger
Adaptimmune Therapeutics
Chief Operating Officer
James Noble
Adaptimmune Therapeutics
Chief Executive Officer
Rafael Amado
Adaptimmune Therapeutics